Clinical trials: Adaptive Immunity
Transplant, Adaptive Immunity
CNTRP POSITIVE Study
Adequate control of immunosuppression is critical in preventing graft failure after solid organ transplantation (SOT) and in avoiding life-threatening viral and malignant complications.
- Conditions
- Transplant, Adaptive Immunity, EBV, Medication Adherence
- Trial name
- NCT02318030
- Where
- Canada
- Volunteers
- 600 people
- Sponsor
- The Hospital for Sick Children
HIV Negative, Adaptive Immunity
Immune Responses to Two Experimental HIV Vaccines in Healthy Adults
Background: The primary focus of the Vaccine Research Center (VRC) at the NIH is to develop vaccines for HIV/AIDS. The main purpose of this study is to look in detail at the body s immune response to two experimental HIV vaccines…
- Conditions
- HIV Negative, Adaptive Immunity, Innate Immunity
- Trial name
- NCT01386489
- Testing
- VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Advanced Cancer, ADCC
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
NK cells can persist and expand in vivo following adoptive transfer and may have a role in the treatment of late stage malignancies.
- Conditions
- Advanced Cancer, ADCC, NK Cell Mediated Immunity, Nimotuzumab
- Trial name
- NCT03554889
- Testing
- NK Cell adaptive transfer, Nimotuzumab
- Where
- China
- Volunteers
- 21 people
- Sponsor
- Hangzhou Cancer Hospital